Co-Culturing of Multipotent Mesenchymal Stromal Cells with Autological and Allogenic Lymphocytes


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We studied the effect of autologous and allogeneic lymphocytes on multipotent mesenchymal stromal cells in co-culture. It is shown that changes in multipotent mesenchymal stromal cells and in lymphocytes did not depend on the source of lymphocytes. Contact with lymphocytes triggers expression of HLA-DR molecules on multipotent mesenchymal stromal cells and these cells lose their immune privilege. In multipotent mesenchymal stromal cells, the relative level of expression of factors involved in immunomodulation (IDO1, PTGES, and IL-6) and expression of adhesion molecule ICAM1 increased, while expression of genes involved in the differentiation of multipotent mesenchymal stromal cells remained unchanged. Priming of multipotent mesenchymal stromal cells with IFN did not affect these changes. In turn, lymphocytes underwent activation, expression of HLA-DR increased, subpopulation composition of lymphocytes changed towards the increase in the content of naïve T cells. These findings are important for cell therapy.

About the authors

N. M. Kapranov

Research Center of Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

Yu. O. Davydova

Research Center of Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

I. V. Gal’tseva

Research Center of Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

N. A. Petinati

Research Center of Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

M. V. Bakshinskaitė

Department of Immunology, Faculty of Biology, M. V. Lo-monosov Moscow State University

Email: ndrize@yandex.ru
Russian Federation, Moscow

N. I. Drize

Research Center of Hematology, Ministry of Health of the Russian Federation

Author for correspondence.
Email: ndrize@yandex.ru
Russian Federation, Moscow

L. A. Kuz’mina

Research Center of Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

E. N. Parovichnikova

Research Center of Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow

V. G. Savchenko

Research Center of Hematology, Ministry of Health of the Russian Federation

Email: ndrize@yandex.ru
Russian Federation, Moscow


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies